Synlogic reports fourth quarter and full year 2023 financial results

Cambridge, mass., march 19, 2024 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full year ending december 31, 2023.

SYBX Ratings Summary

SYBX Quant Ranking